Clinical aspects of acute intermittent porphyria in northern Sweden: A population-based study

References

• Anderson K, Sassa S, Bishop D, Desnick R. Disorders of heme biosynthesis: X-linked sideroblastic anemia and the porphyrias. Scriver C, Beaudet A, Sly W, Valle D. The metabolic and molecular bases of inherited disease. 8th edn. New York: McGraw-Hill. 2001;2991–3080.
   Google Scholar
• Thunell S, Floderus Y, Henrichson A, Harper P. Porphyria in Sweden. Pysiolo Res. 2006; 55Suppl. 2:S109–18.
   PubMed Web of Science ®Google Scholar
• Andersson C, Floderus Y, Wikberg A, Lithner F. The W198X and R173W mutations in the porphobilinogen deaminase gene in acute intermittent porphyria have higher clinical penetrance than R167W. A population-based study. 2000; 60:643–8.
   Google Scholar
• Kauppinen R, von und zu Fraunberg M. Molecular and biochemical studies of acute intermittent porphyria in 196 patients and their families. Clin Chem. 2002; 48:1891–900.
   PubMed Web of Science ®Google Scholar
• Kauppinen R, Mustajoki P. Prognosis of acute porphyria: occurrence of acute attacks, precipitating factors, and associated diseases. Medicine. 1992; 71:1–13.
   PubMed Web of Science ®Google Scholar
• Andersson C, Innala E, Backstrom T. Acute intermittent porphyria in women: clinical expression, use and experience of exogenous sex hormones. A population-based study in northern Sweden. J Intern Med. 2003; 254:176–83.
   PubMed Web of Science ®Google Scholar
• Elder GH, Hift RJ, Meissner PN. The acute porphyrias. Lancet. 1997; 349:1613–7.
   PubMed Web of Science ®Google Scholar
• Waldenström J. The porphyrias as inborn errors of metabolism. Am J Med. 1957; 22:758–73.
   PubMed Web of Science ®Google Scholar
• Laiwah AA, Mactier R, McColl KE, Moore MR, Goldberg A. Early-onset chronic renal failure as a complication of acute intermittent porphyria. Q J Med. 1983; 52:92–8.
   PubMedGoogle Scholar
• Andersson C, Lithner F. Hypertension and renal disease in patients with acute intermittent porphyria. J Intern Med. 1994; 236:169–75.
   PubMed Web of Science ®Google Scholar
• Church SE, McColl KEL, Moore MR, Youngs GR. Hypertension and renal impairment as complications of acute porphyria. Nephrol Dial Transplant. 1992; 7:986–90.
   PubMed Web of Science ®Google Scholar
• Andant C, Puy H, Bogard C, Faivre J, Soule JC, Nordmann Y, Deybach JC. Hepatocellular carcinoma in patients with acute hepatic porphyria: frequency of occurrence and related factors. J Hepatol. 2000; 32:933–9.
   PubMed Web of Science ®Google Scholar
• Andersson C, Bjersing L, Lithner F. The epidemiology of hepatocellular carcinoma in patients with acute intermittent porphyria. J Intern Med. 1996; 240:195–201.
   PubMed Web of Science ®Google Scholar
• Bengtsson NO, Hardell L. Porphyrias, porphyrins and hepatocellular cancer. Br J Cancer. 1986; 54:115–7.
   PubMed Web of Science ®Google Scholar
• Gubler JG, Bargetzi MJ, Meyer UA. Primary liver carcinoma in two sisters with acute intermittent porphyria [letter]. Am J Med. 1990; 89:540–1.
   PubMed Web of Science ®Google Scholar
• Lithner F, Wetterberg L. Hepatocellular carcinoma in patients with acute intermittent porphyria. Acta Med Scand. 1984; 215:271–4.
   PubMedGoogle Scholar
• Mauzerall D, Granick S. The occurrence and determination of delta-aminolevulinic acid and porphobilinogen in urine. J Biol Chem. 1956; 219:435–46.
   PubMed Web of Science ®Google Scholar
• Floderus Y, Shoolingin-Jordan PM, Harper P. Acute intermittent porphyria in Sweden Molecular, functional and clinical consequences of some new mutations found in the porphobilinogen deaminase gene. Clin Genet. 2002; 62:288–97.
   PubMed Web of Science ®Google Scholar
• Zanchetti A, Chalmers JP, Arakawa K, Gyarfas I, Hamet P, Hansson L, Julius S, MacMahon S, Mancia G, Me'nard J, Omae T, Reid J, Safar M. The 1993 guidelines for the management of mild hypertension: Memorandum from a WHO/ISH meeting. Blood Pressure. 1993; 2:86–100.
   PubMedGoogle Scholar
• WHO Study Group. Diabetes Mellitus. Technical Report Series 727. Geneva: World Health Organization. 1985:9–17.
   Google Scholar
• Anderson KE. LHRH analogues for hormonal manipulation in acute intermittent porphyria. Semin Hematol. 1989; 26:10–5.
   PubMed Web of Science ®Google Scholar
• Hift RJ, Meissner PN. An analysis of 112 acute porphyric attacks in Cape Town, South Africa: evidence that acute intermittent porphyria and variegate porphyria differ in susceptibility and severity. Medicine. 2005; 84:48–60.
   PubMed Web of Science ®Google Scholar
• Hultdin J, Schmauch A, Wikberg A, Dahlquist G, Andersson C. Acute intermittent porphyria in childhood: a population-based study. Acta Paediatr. 2003; 92:562–8.
   PubMed Web of Science ®Google Scholar
• Kaplan PW, Lewis DV. Juvenile acute intermittent porphyria with hypercholesterolemia and epilepsy: a case report and review of the literature. J Child Neurol. 1986; 1:38–45.
   PubMed Web of Science ®Google Scholar
• Waldenström J. Studien über Porphyrie. Acta Med Scand. 1937; 82Suppl:1–254.
   Google Scholar
• Goldberg A. Acute intermittent porphyria: a study of 50 cases. Q J Med. 1959; 110:183–209.
   Google Scholar
• Zimmerman T, McMillin J, Watson C. Onset of manifestations of hepatic porphyria in relation to the influence of female sex hormones. Arch Intern Med. 1966; 118:229–40.
   PubMedGoogle Scholar
• Mustajoki P, Koskelo P. Hereditary hepatic porphyrias in Finland. Acta Med Scand. 1976; 200:171–8.
   PubMedGoogle Scholar
• Lip GY, McColl KE, Goldberg A, Moore MR. Smoking and recurrent attacks of acute intermittent porphyria. Br Med J. 1991; :302–507.
   PubMed Web of Science ®Google Scholar
• Mustajoki P, Nordmann Y. Early administration of heme arginate for acute porphyric attacks. Arch Intern Med. 1993; 153:2004–8.
   PubMedGoogle Scholar
• Stein J, Tschudy D. Acute intermittent porphyria. A clinical and biochemical study of 46 patients. Medicine. 1970; 49:1–16.
   PubMed Web of Science ®Google Scholar
• Allard SA, Charles PJ, Herrick AL, McColl KE, Scott JT. Antinuclear antibodies and the diagnosis of systemic lupus erythematosus in patients with acute intermittent porphyria. Ann Rheum Dis. 1990; 49:246–8.
   PubMed Web of Science ®Google Scholar
• Allard SA, Scott JT. Systemic lupus erythematosus and acute intermittent porphyria. Br J Rheumatol. 1989; 28:254–6.
   PubMedGoogle Scholar
• Rosemarin JI, Nigro EJ, Levere RD, Mascarenhas BR. Systemic lupus erythematosus and acute intermittent porphyria: coincidence or association?. Arthritis Rheum. 1982; 25:1134–7.
   PubMed Web of Science ®Google Scholar
• Pischik E. Neurological manifestations of acute intermittent porphyria in north western Russia [Medical dissertation]. University of Helsinki. Helsinki. 2006;
   Google Scholar